Sinocare Unveils Innovative Diabetes Solutions at EASD 2025
Sinocare Showcases Innovative Solutions for Diabetes Management
The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, presenting a platform for health innovations. During this prominent event, Sinocare took the opportunity to spotlight its expertise in diabetes management with an industry symposium and networking dinner.
International Experts Praise the iCan CGM System
At the conference, notable figures such as Professor Lori Laffel, Dr. Guido Freckmann, and Professor Julia Mader presented their collaborative efforts on the iCanTM CGM. The symposium focused on key themes such as 'Performance, Practicality, and Pediatrics' while sharing valuable data from recent studies conducted in Germany and the U.S. involving adult and pediatric populations. Attendees were engaged in discussions about the real-world application of CGM systems, which included insights from a prominent pediatric diabetes center. Importantly, the discourse also examined how diabetes technology can positively influence travel and employment opportunities for individuals passionate about aviation.
Global Launch of iCan i6 CGM System
Sinocare's booth showcased the next-generation iCan i6 CGM system, receiving considerable attention from attendees. This advanced system offers 15-day accuracy and improves user experience through various enhancements. Features include a smaller and lighter sensor for easy application, support for 27 languages to cater to a global audience, a built-in altitude compensation algorithm for accuracy at various elevations, and improved mobile application integration that promotes a smooth and globally accessible monitoring experience.
Collaboration with A.Menarini Diagnostics s.r.l
During the symposium, Sinocare's partner, A.Menarini Diagnostics s.r.l, presented the co-branded GlucoMen® iCan CGM system, further emphasizing the importance of collaboration in advancing diabetes care. Menarini effectively highlighted the system’s novel features and clinical benefits, captivating medical professionals with an engaging booth experience.
Building a Comprehensive Diabetes Ecosystem
At a private dinner seminar hosted by Sinocare, the company introduced its innovative "A+C" Diabetes Prevention and Control Ecosystem to key partners. This model combines AGEscan non-invasive screening with CGM technology, facilitating early detection of diabetes risks and timely interventions. Sinocare also unveiled its hospital glucose management solution, which bridges outpatient and inpatient care, enabling comprehensive digital management of diabetes and enhancing both efficiency and quality of patient care.
Sinocare’s participation at EASD 2025 strengthened global partnerships and showcased the integration of cutting-edge technology in addressing clinical and patient needs. By continuing to advance diabetes management solutions, Sinocare embodies its commitment to improving the quality of life for those battling diabetes.
Frequently Asked Questions
What was showcased at EASD 2025?
Sinocare showcased its innovative diabetes management solutions, including the iCan i6 CGM system and the "A+C" Diabetes Prevention and Control Ecosystem.
Who presented at the symposium organized by Sinocare?
Notable speakers included Professor Lori Laffel, Dr. Guido Freckmann, and Professor Julia Mader, who shared their research on the iCan CGM.
What features make the iCan i6 CGM system stand out?
The iCan i6 CGM system features 15-day accuracy, a smaller sensor for easy application, multi-language support, and enhanced mobile app integration.
How does the collaboration with A.Menarini Diagnostics benefit diabetes care?
This collaboration enables the introduction of innovative products like the GlucoMen® iCan CGM system, which enhances diabetes management through shared expertise and resources.
What is the significance of Sinocare's new diabetes ecosystem?
The "A+C" Diabetes Prevention and Control Ecosystem allows for early risk detection and a seamless integration of diabetes management across various healthcare settings, improving patient outcomes.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.